Trading Update & Acquisition

Victrex PLC 05 April 2007 Thursday 5 April 2007 Victrex plc Acquisition of Minority Stake in Japanese Joint Venture Interim Trading Update Victrex is pleased to announce the acquisition from Mitsui Chemicals, Inc. of their 49% shareholding in Victrex-MC, Inc, our Japanese joint venture. As a result, Victrex-MC, Inc., which is responsible for VICTREX(R) PEEK polymer sales in Japan, became a wholly-owned subsidiary of Victrex plc as of 30 March 2007 and will be renamed Victrex Japan, Inc. The cash consideration paid by Victrex plc was JPY 531.5 million (approximately £2.3m). David Hummel, Chief Executive of Victrex plc, commented: 'This is another milestone in Victrex's continued commitment to the Japanese market. We appreciate the partnership and support of Mitsui Chemicals over the last nine and half years to establish a vibrant and healthy business. Victrex Japan, Inc. will continue to invest in personnel, products and services to support our customers and further grow our business in Japan.' Dr. Shigeru Isayama, Executive Officer and General Manager of the Information & Electronics Materials Division, Performance Materials Business Sector of Mitsui Chemicals, Inc. and former President of Victrex-MC, Inc. commented: 'Mitsui Chemicals has enjoyed its successful collaboration with Victrex and wishes Victrex Japan, Inc. the best for its future and that of its customers.' Interim Trading Update The Company announces its trading update for the six months ended 31 March 2007. Continued sales growth has been achieved, resulting in first half sales volume of approximately 1,285 tonnes, some 5% ahead of the strong second half of last year (1,226 tonnes) and 15% up on the previous first half of 1,113 tonnes. •At 240 tonnes, Asia-Pacific sales have regained momentum, up around 14% on the second half of last year (210 tonnes) and the previous first half (209 tonnes). •European sales saw continued growth at 656 tonnes, 3% up on the second half of last year (640 tonnes) and 18% up on the previous first half (556 tonnes). •United States volume continued to grow with volume of 389 tonnes, 3% ahead of last year's second half of 376 tonnes and 12% ahead of the previous first half of 348 tonnes. •Revenues of Invibio(R), the medical implant materials business, grew by approximately 20% on last year's second half of £7.8m and by approximately 24% on the previous first half of £7.6m. The announcement of the Company's results for the six months ended 31 March 2007 will be made on Tuesday, 5 June 2007. -Ends- For further information please contact: Victrex plc 01253 897700 Michael Peacock, Finance Director Hogarth Partnership Limited 0207 357 9477 Nick Denton / Barnaby Fry Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX(R) PEEKa polymer, a high performance, easy to process thermoplastic. VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis and temperature resistance, as well as excellent dimensional, mechanical and chemical stability combined with inherent purity and low flammability. End users specify VICTREX PEEK to reduce systems costs, improve part performance, exploit greater design freedom and create a differentiated application. VICTREX PEEK is used across a broad range of applications in diverse markets including transport, industrial, electronics and medical. Invibio(R), Victrex's biomaterial business, provides specialised solutions for medical device manufacturers. The Group's headquarters are in the UK where its manufacturing facilities are based. This is complemented by a global network of sales, distribution and technical centres that serve more than 30 countries worldwide. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Victrex plc (VCT)
UK 100

Latest directors dealings